Express News | Lexaria : Study Work Has Already Begun With Completion and Final Reporting Expected in May, 2025

ReutersNov 14 09:14 ET

Express News | Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study; Terms Not Disclosed

BenzingaNov 14 09:12 ET

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

AccesswireNov 13 09:20 ET

Positive Partial 12-Week Blood Sugar Results From Lexaria's GLP-1 Diabetes Animal Study

AccesswireOct 24 09:10 ET

Express News | Lexaria Bioscience Corp: Positive Partial 12-Week Body Weight Results From Lexaria’s GLP-1 Diabetes Animal Study

ReutersOct 22 09:22 ET

Companies Like Lexaria Bioscience (NASDAQ:LEXX) Are In A Position To Invest In Growth

Yahoo FinanceOct 16 11:05 ET